Get started
NOVARTIS AGNOVARTIS AGNOVARTIS AG

NOVARTIS AG

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

NOVN/N chart


Full chart

NOVN/N upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.24 T‬ MXN
Dividend yield (indicated)
3.72%
Price to earnings Ratio (TTM)
16.42
Basic EPS (TTM)
132.12 MXN
Net income (FY)
‪241.42 B‬ MXN
Revenue (FY)
‪1.02 T‬ MXN
Shares float
‪1.69 B‬
Beta (1Y)
0.92

Employees


Employees (FY)
‪75.88 K‬
Change (1Y)
−174 −0.23%
Revenue / Employee (1Y)
‪13.41 M‬ MXN
Net income / Employee (1Y)
‪3.18 M‬ MXN

About NOVARTIS N


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vasant Narasimhan
Website
novartis.com
Headquarters
Basel
Founded
1996
ISIN
CH0012005267
FIGI
BBG017NGCWR9
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NOVN/N news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NOVN/N highest yielding bonds


US66989HAS7
NOVARTIS CAP 20/50
Yield to maturity
6.78%
Maturity date
Aug 14, 2050
XPND
NOVARTIS CAPITAL 15/45
Yield to maturity
6.06%
Maturity date
Nov 20, 2045
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042
Yield to maturity
6.00%
Maturity date
Sep 21, 2042
US66989HAH1
NOVARTIS CAPITAL 14/44
Yield to maturity
5.88%
Maturity date
May 6, 2044
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054
Yield to maturity
5.83%
Maturity date
Sep 18, 2054
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034
Yield to maturity
5.02%
Maturity date
Sep 18, 2034
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031
Yield to maturity
4.56%
Maturity date
Sep 18, 2031
XPNC
NOVARTIS CAPITAL 15/25
Yield to maturity
4.55%
Maturity date
Nov 20, 2025
US66989HAR9
NOVARTIS CAP 20/30
Yield to maturity
4.53%
Maturity date
Aug 14, 2030
NVS5894398
Novartis Capital Corp. 3.8% 18-SEP-2029
Yield to maturity
4.27%
Maturity date
Sep 18, 2029
US66989HAN8
NOVARTIS CAPITAL 17/27
Yield to maturity
4.16%
Maturity date
May 17, 2027

See all NOVN/N bonds 

Sparks


Curated watchlists where NOVN/N is featured.

See all sparks 


Check out other big names from the same industry as NOVN/N.

Frequently Asked Questions


The current price of NOVN/N is 2,207.59 MXN — it hasn't changed in the past 24 hours. Watch NOVARTIS AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange NOVARTIS AG stocks are traded under the ticker NOVN/N.
NOVN/N stock hasn't changed in a week, the month change is a 0.16% rise, over the last year NOVARTIS AG has showed a 28.40% increase.
We've gathered analysts' opinions on NOVARTIS AG future price: according to them, NOVN/N price has a max estimate of 2,976.33 MXN and a min estimate of 1,854.64 MXN. Watch NOVN/N chart and read a more detailed NOVARTIS AG stock forecast: see what analysts think of NOVARTIS AG and suggest that you do with its stocks.
NOVN/N reached its all-time high on Apr 1, 2025 with the price of 2,277.94 MXN, and its all-time low was 1,719.29 MXN and was reached on Jul 19, 2023. View more price dynamics on NOVN/N chart.
See other stocks reaching their highest and lowest prices.
NOVN/N stock is 0.00% volatile and has beta coefficient of 0.92. Track NOVARTIS AG stock price on the chart and check out the list of the most volatile stocks — is NOVARTIS AG there?
Today NOVARTIS AG has the market capitalization of ‪4.23 T‬, it has decreased by −3.05% over the last week.
Yes, you can track NOVARTIS AG financials in yearly and quarterly reports right on TradingView.
NOVARTIS AG is going to release the next earnings report on Jul 17, 2025. Keep track of upcoming events with our Earnings Calendar.
NOVN/N earnings for the last quarter are 46.71 MXN per share, whereas the estimation was 43.31 MXN resulting in a 7.86% surprise. The estimated earnings for the next quarter are 45.25 MXN per share. See more details about NOVARTIS AG earnings.
NOVARTIS AG revenue for the last quarter amounts to ‪271.11 B‬ MXN, despite the estimated figure of ‪268.01 B‬ MXN. In the next quarter, revenue is expected to reach ‪274.44 B‬ MXN.
NOVN/N net income for the last quarter is ‪75.02 B‬ MXN, while the quarter before that showed ‪56.76 B‬ MXN of net income which accounts for 32.17% change. Track more NOVARTIS AG financial stats to get the full picture.
Yes, NOVN/N dividends are paid annually. The last dividend per share was 80.30 MXN. As of today, Dividend Yield (TTM)% is 3.72%. Tracking NOVARTIS AG dividends might help you take more informed decisions.
NOVARTIS AG dividend yield was 3.95% in 2024, and payout ratio reached 67.17%. The year before the numbers were 3.89% and 51.36% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 4, 2025, the company has ‪75.88 K‬ employees. See our rating of the largest employees — is NOVARTIS AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS AG EBITDA is ‪456.61 B‬ MXN, and current EBITDA margin is 42.72%. See more stats in NOVARTIS AG financial statements.
Like other stocks, NOVN/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS AG stock right from TradingView charts — choose your broker and connect to your account.